Globus Medical Retained Earnings (Accumulated Deficit) 2010-2024 | GMED
Globus Medical retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Globus Medical retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $1.153B, a 1.37% increase year-over-year.
- Globus Medical retained earnings (accumulated deficit) for 2024 were $1.153B, a 1.37% increase from 2023.
- Globus Medical retained earnings (accumulated deficit) for 2023 were $1.137B, a 8.28% decline from 2022.
- Globus Medical retained earnings (accumulated deficit) for 2022 were $1.24B, a 3.82% increase from 2021.
| Globus Medical Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $1,153 |
| 2023 | $1,137 |
| 2022 | $1,240 |
| 2021 | $1,194 |
| 2020 | $1,045 |
| 2019 | $1,048 |
| 2018 | $893 |
| 2017 | $736 |
| 2016 | $629 |
| 2015 | $525 |
| 2014 | $412 |
| 2013 | $319 |
| 2012 | $251 |
| 2011 | $177 |
| 2010 | $126 |
| 2009 | $0 |
| Globus Medical Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,153 |
| 2024-09-30 | $1,126 |
| 2024-06-30 | $1,074 |
| 2024-03-31 | $1,047 |
| 2023-12-31 | $1,137 |
| 2023-09-30 | $1,348 |
| 2023-06-30 | $1,347 |
| 2023-03-31 | $1,289 |
| 2022-12-31 | $1,240 |
| 2022-09-30 | $1,190 |
| 2022-06-30 | $1,142 |
| 2022-03-31 | $1,232 |
| 2021-12-31 | $1,194 |
| 2021-09-30 | $1,179 |
| 2021-06-30 | $1,132 |
| 2021-03-31 | $1,090 |
| 2020-12-31 | $1,045 |
| 2020-09-30 | $992 |
| 2020-06-30 | $948 |
| 2020-03-31 | $1,000 |
| 2019-12-31 | $1,048 |
| 2019-09-30 | $1,002 |
| 2019-06-30 | $964 |
| 2019-03-31 | $926 |
| 2018-12-31 | $893 |
| 2018-09-30 | $856 |
| 2018-06-30 | $821 |
| 2018-03-31 | $776 |
| 2017-12-31 | $736 |
| 2017-09-30 | $712 |
| 2017-06-30 | $686 |
| 2017-03-31 | $658 |
| 2016-12-31 | $629 |
| 2016-09-30 | $605 |
| 2016-06-30 | $578 |
| 2016-03-31 | $553 |
| 2015-12-31 | $525 |
| 2015-09-30 | $487 |
| 2015-06-30 | $460 |
| 2015-03-31 | $436 |
| 2014-12-31 | $412 |
| 2014-09-30 | $384 |
| 2014-06-30 | $361 |
| 2014-03-31 | $340 |
| 2013-12-31 | $319 |
| 2013-09-30 | $298 |
| 2013-06-30 | $278 |
| 2013-03-31 | $271 |
| 2012-12-31 | $251 |
| 2012-09-30 | $230 |
| 2012-06-30 | $213 |
| 2012-03-31 | $194 |
| 2011-12-31 | $177 |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | $126 |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $9.891B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||